类固醇耐火性免疫检查点诱导的急性间歇性炎被mycophenolate mofetil拯救
Prashanth Moku1,2, Brianna Bakow1,2, Arun Muthiah3
1Alpert Medical School Brown University.
The Brown journal of hospital medicine
|March 6, 2025
概括
免疫检查点抑制剂 (ICI) 可以引起自身免疫性副作用,如急性间歇性炎 (AIN). 在转移性膀癌患者中,mycophenolate mofetil有效地治疗了对类固醇耐药的AIN.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 免疫检查点抑制剂 (ICI) 通过增强抗瘤免疫力,改变了癌症治疗.
- 对ICI的一个重大挑战是免疫相关不良事件 (irAEs) 的发生,这些不良事件涉及免疫系统攻击健康组织.
- 急性间歇性炎 (AIN) 是一种公认的性炎.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K


